Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of Inactivated SARS-CoV-2 Vaccines (WIBP and BIBP) in Healthy Adults
NCT04510207Phase 3Completed
- Sponsor
- China National Biotec Group
- Start
- Jul 2020
- Primary completion
- Jun 2021
- Modality
- Whole Inactivated Vaccines
- Countries
- 4
01
Overview
A Phase 3 trial of inactivated SARS-CoV-2 vaccine (WIBP), BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by China National Biotec Group. Started Jul 2020; status: completed.
02
Drugs
inactivated SARS-CoV-2 vaccine (WIBP)BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04510207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04510207.